New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today

Join Baptist Health's Dr. Geoffrey Young as he joins Drs. Sonia Cohen and Ashley Holder on the latest episode of SurgOnc Today.

  • By

  • August 28, 2026

  • 1 min

Share

Clinical Scorecard: New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today

At a Glance

CategoryDetail
ConditionSkin Cancers
Key MechanismsSentinel lymph node procedures
Target PopulationPatients with skin cancers
Care SettingSurgical oncology

Key Highlights

  • Discussion on sentinel lymph node procedures
  • Considerations for staging skin cancers
  • Decision-making factors in complex cases
  • Practical perspectives from surgical oncologists

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regular follow-up for staging accuracy

      Risks

      • Potential complications from sentinel lymph node procedures

      Patient & Prescribing Data

      Patients undergoing sentinel lymph node procedures for skin cancers

      Focus on decision-making in challenging cases

      Clinical Best Practices

      • Engage in multidisciplinary discussions for complex cases
      • Consider individual patient factors in decision-making

      Related Resources & Content

      Original Source(s)

      New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today

      • by

      • August 28, 2026

      Related Content

      Cancer Communication in an Era of Fragmented Trust

      Coding for Ocular Tumors

      Ocular tumor coding can be challenging because ocular oncology often involves evolving lesions, diagnostic uncertainty, and terminology that does not always translate cleanly into ICD-10-CM codes. Understanding how to distinguish benign, malignant, in situ, and uncertain histologic behavior neoplasms is essential for accurate coding, medical necessity, and audit defensibility.

      This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

      A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

      • August 31, 2026

      • 5 min